JavaScript is disabled for your browser. Some features of this site may not work without it.
Different in vitro experimental approaches to treat breast cancer: from combination treatment of olaparib, oxaliplatin and PI3K inhibitor to targeting the mitochondria with a novel Mito-CP derivative HO-5114
